11
Views
31
CrossRef citations to date
0
Altmetric
Original Article

The Cost of Prostatic Cancer in a Defined Population

, , &
Pages 93-96 | Received 09 Mar 1988, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Karin Sennfält, Per Carlsson, Johan Thorfinn, Jessica Frisk, Martin Henriksson & Eberhard Varenhorst. (2003) Technological Changes in the Management of Prostate Cancer Result in Increased Healthcare Costs: A Retrospective Study in a Defined Swedish Population. Scandinavian Journal of Urology and Nephrology 37:3, pages 226-231.
Read now
Anders Norlund, Thor Alvegård, Thor Lithman, Juan Merlo & Dennis Noreen. (2003) Prostate cancerPrevalence‐based healthcare costs. Scandinavian Journal of Urology and Nephrology 37:5, pages 371-375.
Read now
Klaus Brasso, Peter Iversen. (1999) Prostate Cancer in Denmark: Incidence, Morbidity and Mortality. Scandinavian Journal of Urology and Nephrology 33:203, pages 29-33.
Read now
Håkan Holmberg, Per Carlsson, Disa Kalman, Eberhard Varenhorst. (1998) Impact on Health Service Costs of Medical Technologies Used in Management of Prostatic Cancer. Scandinavian Journal of Urology and Nephrology 32:3, pages 195-199.
Read now
Michael Borre, Benni Nerstrøm & Jens Overgaard. (1997) The Dilemma of Prostate Cancer: A Growing Human and Economic Burden Irrespective of Treatment Strategies. Acta Oncologica 36:7, pages 681-687.
Read now
. (1996) Chapter 8: Cost of Radiotherapy in Sweden. Acta Oncologica 35:sup6, pages 57-71.
Read now

Articles from other publishers (24)

Shuang Hao, Ellinor Östensson, Martin Eklund, Henrik Grönberg, Tobias Nordström, Emelie Heintz & Mark Clements. (2020) The economic burden of prostate cancer – a Swedish prevalence-based register study. BMC Health Services Research 20:1.
Crossref
John M. Fitzpatrick, Claude Schulman, Alexandre R. Zlotta & Fritz H. Schröder. (2009) Prostate cancer: a serious disease suitable for prevention. BJU International 103:7, pages 864-870.
Crossref
Laurent Molinier, Eric Bauvin, Christophe Combescure, Christel Castelli, Xavier Rebillard, Michel Soulié, Jean-Pierre Daurès & Pascale Grosclaude. (2008) Methodological Considerations in Cost of Prostate Cancer Studies: A Systematic Review. Value in Health 11:5, pages 878-885.
Crossref
Karin Sennfält, Per Carlsson & Eberhard Varenhorst. (2006) Diffusion and Economic Consequences of Health Technologies in Prostate Cancer Care in Sweden, 1991–2002. European Urology 49:6, pages 1028-1034.
Crossref
Marco Turini, Alberto Redaelli, Paola Gramegna & Davide Radice. (2003) Quality of Life and Economic Considerations in the Management of Prostate Cancer. PharmacoEconomics 21:8, pages 527-541.
Crossref
Fernand Labrie. (2002) Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease. Molecular and Cellular Endocrinology 198:1-2, pages 77-87.
Crossref
N Y Piper, L Kusada, R Lance, J Foley, J Moul & T Seay. (2002) Adenocarcinoma of the prostate: an expensive way to die. Prostate Cancer and Prostatic Diseases 5:2, pages 164-166.
Crossref
Christopher S. Saigal & Mark S. Litwin. (2002) The Economic Costs of Early Stage Prostate Cancer. PharmacoEconomics 20:13, pages 869-878.
Crossref
Hirsch S. Ruchlin & James M. Pellissier. (2001) An economic overview of prostate carcinoma. Cancer 92:11, pages 2796-2810.
Crossref
J. Hugosson, G. Aus, C. Becker, S. Carlsson, H. Eriksson, H. Lilja, P. Lodding & G. Tibblin. (2001) Would prostate cancer detected by screening withprostate‐specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population‐based studies in Sweden. BJU International 85:9, pages 1078-1084.
Crossref
KLAUS BRASSO &NA;S??REN FRIIS, KNUD JUEL, TORBEN J??RGENSEN & PETER ERSENIVIV. (2000) THE NEED FOR HOSPITAL CARE OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER MANAGED BY NONCURATIVE INTENT:. The Journal of Urology, pages 1150-1154.
Crossref
KLAUS BRASSO, SØREN FRIIS, KNUD JUEL, TORBEN JØRGENSEN & PETER ERSEN. (2000) THE NEED FOR HOSPITAL CARE OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER MANAGED BY NONCURATIVE INTENT: A POPULATION BASED REGISTRY STUDY. Journal of Urology 163:4, pages 1150-1154.
Crossref
Irena Malmberg, Ulf Persson, Anders Ask, Jan Tennvall & Per-Anders Abrahamsson. (1997) Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy. Urology 50:5, pages 747-753.
Crossref
Jonas Hugosson, Gunnar Aus & Lars Norlén. (1996) SURVEILLANCE IS NOT A VIABLE AND APPROPRIATE TREATMENT OPTION IN THE MANAGEMENT OF LOCALIZED PROSTATE CANCER. Urologic Clinics of North America 23:4, pages 557-573.
Crossref
B. OTNES, S. HARVEI & S.D. FOSSÅ. (2008) The burden of prostate cancer from diagnosis until death. British Journal of Urology 76:5, pages 587-594.
Crossref
G. Aus, J. Hugosson & L. Norlen. (1995) Need for Hospital Care and Palliative Treatment for Prostate Cancer Treated with Noncurative Intent. The Journal of Urology, pages 466-469.
Crossref
G. AusJ. HugossonL. Norlen. (1995) Need for Hospital Care and Palliative Treatment for Prostate Cancer Treated with Noncurative Intent. Journal of Urology 154:2, pages 466-469.
Crossref
G. Vagliani, A. Perrone, G. Salvi, G. Misuriello, A. Di Silverio, V. ValmoriG. Mauceri, S. Creti, G. Batoumeni & M. Fini. (2018) Impatto economico del cancro della prostata nel comprensorio dell'ULSS n. 23 di Imola. Urologia Journal 61:1_suppl, pages 51-56.
Crossref
G.J. Bonsel, F.F.H. Rutten & C.A. Uyl-de Groot. (1993) Economic evaluation alongside cancer trials: Methodological and practical aspects. European Journal of Cancer 29, pages S10-S14.
Crossref
M. FiniG. VaglianiA. PerroneG. SalviG. MisurielloA. Di SilverioM. Milani. (2018) Validity of Transrectal Ultrasonography in the Early Diagnosis and Staging of Prostatic Cancer. Urologia Journal 59:2, pages 59-65.
Crossref
Simon Schraub, Michel Mougeot, Mariette Mercier & Pierre Bourgeois. (1991) Evaluation from population registry data of health care expenditure during the 6 months after cancer diagnosis. Health Policy 18:3, pages 219-229.
Crossref
T. E. B. JOHANSEN & H. T. FJAERE. (2008) Hospitalisation of Prostatic Cancer Patients Undergoing Orchiectomy. British Journal of Urology 68:1, pages 62-66.
Crossref
Per Carlsson, Knud V. Pedersen & Eberhard Varenhorst. (1990) Costs and benefits of early detection of prostatic cancer. Health Policy 16:3, pages 241-253.
Crossref
B. Jönsson & G. Karlsson. 1990. Drug Delivery in Cancer Treatment III. Drug Delivery in Cancer Treatment III 63 84 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.